mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.003 |